155 related articles for article (PubMed ID: 23218868)
1. Perceptions of generic drug discount programs among low-income women: a qualitative study.
Omojasola A; Gor B; Jones L
Womens Health Issues; 2013 Jan; 23(1):e55-60. PubMed ID: 23218868
[TBL] [Abstract][Full Text] [Related]
2. Predictors of $4 generic prescription drug discount programs use in the low-income population.
Omojasola A; Hernandez M; Sansgiry S; Paxton R; Jones L
Res Social Adm Pharm; 2014; 10(1):141-8. PubMed ID: 23684716
[TBL] [Abstract][Full Text] [Related]
3. Federally qualified health center patients and generic drug discount programs.
Omojasola A; Hernandez M; Sansgiry SS; Paxton R; Jones L
J Health Care Poor Underserved; 2012 Feb; 23(1):358-66. PubMed ID: 22643483
[TBL] [Abstract][Full Text] [Related]
4. Perception of generic prescription drugs and utilization of generic drug discount programs.
Omojasola A; Hernandez M; Sansgiry S; Jones L
Ethn Dis; 2012; 22(4):479-85. PubMed ID: 23140080
[TBL] [Abstract][Full Text] [Related]
5. Federally qualified health center patients and generic drug discount programs.
Omojasola A; Hernandez M; Sansgiry S; Paxton R; Jones L
J Health Care Poor Underserved; 2012 May; 23(2):875-83. PubMed ID: 22643630
[TBL] [Abstract][Full Text] [Related]
6. An Emergency Department Pilot Study to Save Money for Patients through use of Retail Pharmacy Generic Drug Discount Programs.
Dalawari P; Kantipudi A; Fitzgerald J
J Health Care Poor Underserved; 2018; 29(4):1356-1367. PubMed ID: 30449751
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictors of utilization of community pharmacy generic drug discount programs.
Gatwood J; Tungol A; Truong C; Kucukarslan SN; Erickson SR
J Manag Care Pharm; 2011; 17(6):449-55. PubMed ID: 21787030
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in beliefs of physician prescribing practices for low-cost pharmacy options.
Dalawari P; Patel NM; Bzdawka W; Petrone J; Liou V; Armbrecht E
J Emerg Med; 2014 Mar; 46(3):396-403. PubMed ID: 24126066
[TBL] [Abstract][Full Text] [Related]
9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
10. Medicare beneficiaries' out-of-pocket costs for commonly used generic drugs, 2009-2017.
Liu P; Dhruva SS; Shah ND; Ross JS
Am J Manag Care; 2020 Mar; 26(3):112-117. PubMed ID: 32181626
[TBL] [Abstract][Full Text] [Related]
11. Encouraging generic use can yield significant savings.
Zimmerman C
Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
[TBL] [Abstract][Full Text] [Related]
12. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
13. Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data.
Farfan-Portet MI; Van de Voorde C; Vrijens F; Vander Stichele R
Eur J Health Econ; 2012 Jun; 13(3):301-13. PubMed ID: 22427042
[TBL] [Abstract][Full Text] [Related]
14. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
Brouwer ED; Basu A; Yeung K
Pharmacoeconomics; 2019 Oct; 37(10):1287-1300. PubMed ID: 31270747
[TBL] [Abstract][Full Text] [Related]
15. Impact of brand drug discount cards on private insurer, government and patient expenditures.
Law MR; Chan FKI; Harrison M; Worthington HC
CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
[TBL] [Abstract][Full Text] [Related]
16. Private expenditures on brand name prescription drugs after generic entry.
Balaban DY; Dhalla IA; Law MR; Bell CM
Appl Health Econ Health Policy; 2013 Oct; 11(5):523-9. PubMed ID: 23979876
[TBL] [Abstract][Full Text] [Related]
17. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
18. Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.
Roebuck MC; Liberman JN
Health Serv Res; 2009 Jun; 44(3):988-1009. PubMed ID: 19187183
[TBL] [Abstract][Full Text] [Related]
19. Impact of a commercial accountable care organization on prescription drugs.
Zhang H; Cowling DW; Graham JM; Taylor E
Health Serv Res; 2021 Aug; 56(4):592-603. PubMed ID: 33508877
[TBL] [Abstract][Full Text] [Related]
20. Reducing the burden of medication costs to improve medication adherence.
Shaw CR
Nurse Pract; 2014 Jul; 39(7):43-7. PubMed ID: 24932794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
